Jun 2026 (Q2 FY26) — Aug 7, 2026
SANUWAVE Health Q2 FY26 — Strong Consumables Growth Amidst Reimbursement Uncertainty and Used System Cannibalization
Read the full callSANUWAVE Health (SNWV) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
SANUWAVE Health earnings: last reported Fri, 7 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 9.7 | −3.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -2.9 | −17.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -0.68 | −223.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$4.83 −2.62% · −$0.13
Performance −85.8% 1Y
1Y: $33.93 on 17 Oct 2025 → $4.83. High $35.34 (11 Nov 2025), low $4 (10 Sept 2026).
- Previous close
- $4.96
- 52-week range
- $4 – $35.34
- One year
- −84.57%
Overview
- Symbol
- SNWV
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
SANUWAVE Health earnings calls (SNWV)
Financials
What the filings say
Net profit, year on year: −224% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 9 | 10 | 9 | 10 | 11 | 13 | 10 | 10 |
| Operating profit | 1 | 3 | 1 | 1 | 1 | 2 | -1 | -0 |
| Operating margin | 15.8% | 24.4% | 6.4% | 14.3% | 8.0% | 14.9% | −11.7% | −2.9% |
| Net profit | -21 | -13 | -6 | 1 | 10 | 8 | -1 | -1 |
| EPS ($ per share) | -6.65 | — | -0.72 | 0.06 | 1.13 | — | -0.17 | -0.08 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Reserves | -117 | -126 | -157 | -184 | -194 | -220 | -254 | -243 |
| Total liabilities | 17 | 13 | 37 | 58 | 61 | 66 | 46 | 36 |
| Fixed assets | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 2 |
| Total assets | 1 | 3 | 23 | 19 | 20 | 22 | 30 | 37 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4 | -6 | -13 | -6 | -17 | -5 | 2 | 4 |
| Cash from investing | -0 | -0 | -20 | -1 | 0 | 0 | -0 | 3 |
| Cash from financing | 3 | 8 | 33 | 5 | 17 | 5 | 6 | -6 |
| Net cash flow | — | 1 | 1 | -2 | 1 | 1 | 8 | 2 |
| Capital expenditure | -0 | -0 | -0 | -1 | — | 0 | -0 | -2 |
| Free cash flow | -4 | -6 | -13 | -7 | — | -5 | 2 | 2 |
Insider filings
17 filings between Dec 8, 2025 and May 1, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$7.20M
17 sales by 2 insiders
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| MANCHESTER MANAGEMENT CO LLC | — | $5.01M | Dec 12, 2025 |
| Opaleye Management Inc. | — | $2.19M | May 1, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | Opaleye Management Inc. 10% owner | Sale | 10,081 | $162.4K |
| May 1, 2026 | Opaleye Management Inc. 10% owner | Sale | 500 | $8.1K |
| Apr 30, 2026 | Opaleye Management Inc. 10% owner | Sale | 1,000 | $16.2K |
| Apr 30, 2026 | Opaleye Management Inc. 10% owner | Sale | 24,000 | $387.6K |
| Apr 29, 2026 | Opaleye Management Inc. 10% owner | Sale | 23,360 | $402.9K |
| Apr 29, 2026 | Opaleye Management Inc. 10% owner | Sale | 1,000 | $17.2K |
| Apr 28, 2026 | Opaleye Management Inc. 10% owner | Sale | 43,788 | $808.7K |
| Apr 28, 2026 | Opaleye Management Inc. 10% owner | Sale | 2,500 | $46.2K |
| Apr 21, 2026 | Opaleye Management Inc. 10% owner | Sale | 202 | $4.1K |
| Apr 17, 2026 | Opaleye Management Inc. 10% owner | Sale | 11,267 | $230.5K |
| Apr 17, 2026 | Opaleye Management Inc. 10% owner | Sale | 5,000 | $102.3K |
| Dec 12, 2025 | MANCHESTER MANAGEMENT CO LLC Insider | Sale | 6,500 | $136.8K |
| Dec 11, 2025 | MANCHESTER MANAGEMENT CO LLC Insider | Sale | 13,500 | $422.3K |
| Dec 10, 2025 | MANCHESTER MANAGEMENT CO LLC Insider | Sale | 8,625 | $262.1K |
| Dec 9, 2025 | MANCHESTER MANAGEMENT CO LLC Insider | Sale | 8,785 | $268.7K |
| Dec 8, 2025 | MANCHESTER MANAGEMENT CO LLC Insider | Sale | 125,400 | $3.86M |
| Dec 8, 2025 | MANCHESTER MANAGEMENT CO LLC Insider | Sale | 2,000 | $63.2K |
| Oct 6, 2025 | Opaleye Management Inc. 10% owner | Purchase | 1,267 | $38.4K |
| Jun 5, 2025 | Stegagno Peter Chief Operating Officer | Option exercise | 529 | $11.9K |
| Jun 5, 2025 | Stegagno Peter Chief Operating Officer | Sale | 1,862 | $51.6K |
| Jun 5, 2025 | Stegagno Peter Chief Operating Officer | Option exercise | 1,333 | $20.0K |
| Apr 29, 2025 | Opaleye Management Inc. 10% owner | Purchase | 2,998 | $76.4K |
| Apr 29, 2025 | Opaleye Management Inc. 10% owner | Purchase | 5,000 | $127.5K |
| Nov 1, 2024 | Opaleye Management Inc. 10% owner | Purchase | 7,998 | $121.5K |
| Nov 1, 2024 | Opaleye Management Inc. 10% owner | Purchase | 8,002 | $121.6K |
| Oct 31, 2024 | Opaleye Management Inc. 10% owner | Purchase | 5,868 | $95.6K |
| Oct 31, 2024 | Opaleye Management Inc. 10% owner | Purchase | 4,000 | $65.2K |
| Oct 30, 2024 | Opaleye Management Inc. 10% owner | Purchase | 2,000 | $35.0K |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 8,500 | — |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 9,000 | — |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 11,500 | — |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 5,100 | — |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 5,400 | — |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 76,215 | — |
| Oct 18, 2024 | Stolarski Anthony Michael Director | Award | 80,698 | — |
| Oct 18, 2024 | Miller Ian D. Director | Award | 3,000 | — |
| Oct 18, 2024 | Miller Ian D. Director | Award | 6,300 | — |
| Oct 18, 2024 | Miller Ian D. Director | Award | 5,950 | — |
| Oct 18, 2024 | Miller Ian D. Director | Award | 2,834 | — |
| Oct 18, 2024 | Tyler James Director | Award | 2,700 | — |
| Oct 18, 2024 | Tyler James Director | Award | 2,550 | — |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 42,498 | $1.07M |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 14,167 | $356.0K |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 15,000 | $225.0K |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 22,667 | $569.6K |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 24,000 | $360.0K |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Purchase | 181,818 | $1.50M |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 6,375 | $160.2K |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 150,000 | $2.25M |
| Oct 18, 2024 | MANCHESTER MANAGEMENT CO LLC Insider | Other | 141,667 | $3.56M |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for SANUWAVE Health, Inc.
Free account. Everything above stays public.
Write why you follow SANUWAVE Health, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading